A Study to Assess CT-868 and the Relationship Between Insulin Secretory Response and Ambient Blood Glucose
Clinical trial NCT04973111 · COMPLETED
Trial details
- NCT number
- NCT04973111
- Sponsor
- Carmot Therapeutics, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-07-16
- Primary completion
- 2022-04-22
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.